Form 4: Intuitive Surgical EVP Myriam Curet Reports Stock Transactions
SEC Form 4
Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, reports the vesting and sale of common stock and restricted stock units.
Summary
- Myriam Curet, an Executive Vice President and Chief Medical Officer at Intuitive Surgical Inc. (ISRG), reported transactions involving the company's common stock and Restricted Stock Units (RSUs).
- On February 26, 2024, Curet exercised 1,710 RSUs, converting them into common stock.
- Also on February 26, 2024, 867 shares were disposed of to cover tax withholding requirements at a price of $389.77.
- On February 27, 2024, Curet sold 843 shares of common stock at a price of $386.46 per share.
- Following these transactions, Curet directly owns 298 shares of common stock and 1,710 Restricted Stock Units that vest on 02/26/2025.
- Curet also owns 9,158 Restricted Stock Units that vest over three years.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an executive, and does not inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
Executive stock transactions are a normal part of corporate governance and executive compensation. These transactions are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and trading plans described in the document are typical for executive compensation in publicly traded companies.
- Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may be interested in the transactions as an indicator of executive sentiment, but the amounts are relatively small.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Exercise of 1,710 RSUs and disposal of 867 shares for tax obligations. |
| 02/26/2025 | Vesting date for 1,710 Restricted Stock Units. |
| 02/27/2024 | Sale of 843 shares of common stock. |
| August 12, 2024 | Expiration date of the Rule 10b5-1 trading plan. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.